Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 8428 [2017-01627]
Download as PDF
8428
Federal Register / Vol. 82, No. 15 / Wednesday, January 25, 2017 / Notices
‘‘Grants for Injury Prevention and
Control’’, FOA RFA–CE–12–
0010501SUPP16.
Contact Person for More Information:
Oscar Tarrago, M.D., M.P.H., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F63, Atlanta,
Georgia 30341–3724, Telephone: (770)
488–3492.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–01626 Filed 1–24–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
mstockstill on DSK3G9T082PROD with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) PAR 13–129, Occupational Safety
and Health Research, NIOSH Member
Conflict Review.
Time and Date: 1:00 p.m.–5:00 p.m., EST,
March 1, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Occupational Safety and Health
Research, NIOSH Member Conflict Review’’,
PAR 13–129.
Contact Person for More Information: Nina
Turner, Ph.D., Scientific Review Officer,
NIOSH, CDC, 1095 Willowdale Road,
Mailstop G905, Morgantown, West Virginia
26506, Telephone: (304) 285–5976.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Sep<11>2014
20:29 Jan 24, 2017
Jkt 241001
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–01627 Filed 1–24–17; 8:45 am]
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–01629 Filed 1–24–17; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) PS17–003, Innovative InternetBased Approaches to Reach Black and
Hispanic MSM for HIV Testing and
Prevention Services; and FOA PS17–
004, Comparison of Models of PrEP
Service Delivery at Title X and STD
Clinics.
Times and Dates: 10:00 a.m.–5:00
p.m., February 22–23, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion and evaluation of
applications received in response to
‘‘Innovative Internet-Based Approaches
to Reach Black and Hispanic MSM for
HIV Testing and Prevention Services’’,
PS17–003; and ‘‘Comparison of Models
of PrEP Service Delivery at Title X and
STD Clinics’’, PS17–004.
Contact person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30329, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Healthcare Infection Control Practices
Advisory Committee, Department of
Health and Human Services, has been
renewed for a 2-year period through
January 19, 2019.
For information, contact Jeffrey
Hageman, M.H.S., Executive Secretary,
Healthcare Infection Control Practices
Advisory Committee, Department of
Health and Human Services, 1600
Clifton Road NE., Mailstop A35,
Atlanta, Georgia 30329, telephone 404–
639–4951 or fax 404–639–2647.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–01625 Filed 1–24–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Multistate Financial Institution
Data Match with Federally Assisted
State Transmitted Levy (FIDM/FASTLevy).
OMB No. : 0970–0196.
E:\FR\FM\25JAN1.SGM
25JAN1
Agencies
[Federal Register Volume 82, Number 15 (Wednesday, January 25, 2017)]
[Notices]
[Page 8428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01627]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA) PAR
13-129, Occupational Safety and Health Research, NIOSH Member Conflict
Review.
Time and Date: 1:00 p.m.-5:00 p.m., EST, March 1, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Occupational Safety and Health Research, NIOSH Member
Conflict Review'', PAR 13-129.
Contact Person for More Information: Nina Turner, Ph.D.,
Scientific Review Officer, NIOSH, CDC, 1095 Willowdale Road,
Mailstop G905, Morgantown, West Virginia 26506, Telephone: (304)
285-5976.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-01627 Filed 1-24-17; 8:45 am]
BILLING CODE 4163-18-P